Chemoinformaics analysis of D-(+)-Beta-3,4-Dihydrophenyl-Lactic-Acid
| Molecular Weight | 168.192 | nRot | 3 |
| Heavy Atom Molecular Weight | 156.096 | nRig | 9 |
| Exact Molecular Weight | 168.079 | nRing | 1 |
| Solubility: LogS | -0.634 | nHRing | 0 |
| Solubility: LogP | 0.839 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 25.4375 |
| nHD | 2 | BPOL | 12.9065 |
| QED | 0.502 |
| Synth | 2.707 |
| Natural Product Likeliness | 0.217 |
| NR-PPAR-gamma | 0.019 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.013 |
| Pgp-sub | 0.001 |
| HIA | 0.025 |
| CACO-2 | -4.77 |
| MDCK | 0.0000295 |
| BBB | 0.075 |
| PPB | 0.872959 |
| VDSS | 0.281 |
| FU | 0.0904872 |
| CYP1A2-inh | 0.253 |
| CYP1A2-sub | 0.165 |
| CYP2c19-inh | 0.078 |
| CYP2c19-sub | 0.063 |
| CYP2c9-inh | 0.2 |
| CYP2c9-sub | 0.616 |
| CYP2d6-inh | 0.139 |
| CYP2d6-sub | 0.327 |
| CYP3a4-inh | 0.015 |
| CYP3a4-sub | 0.114 |
| CL | 1.069 |
| T12 | 0.851 |
| hERG | 0.015 |
| Ames | 0.342 |
| ROA | 0.043 |
| SkinSen | 0.922 |
| Carcinogencity | 0.73 |
| EI | 0.992 |
| Respiratory | 0.624 |
| NR-Aromatase | 0.02 |
| Antiviral | No |
| Prediction | 0.936883 |